Stanley-Laman Group’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-28,587
Closed -$2.47M 242
2016
Q4
$2.47M Buy
28,587
+16,109
+129% +$1.44M 0.76% 33
2016
Q3
$1.08M Buy
12,478
+1,771
+17% +$178K 0.44% 67
2016
Q2
$1.14M Buy
+10,707
New +$1.1M 0.45% 67

Other funds holding CRI

Stanley-Laman Group's CRI Position: Q1 2017 in Review

Stanley-Laman Group sold out of Carter's (CRI) in Q1 2017, closing a stake of 28,587 shares — an estimated $2.47M sold.

Stanley-Laman Group first reported a position in CRI in Q2 2016 and held it in 3 quarters. The position peaked at $2.47M in Q4 2016. 337 funds tracked by Wall St. Rank hold CRI as of Q1 2017.

  • Stanley-Laman Group reported no remaining Carter's position as of Q1 2017 after selling out during the quarter.
  • Stanley-Laman Group sold 28,587 Carter's shares in Q1 2017, an estimated $2.47M.
  • Stanley-Laman Group first reported a position in Carter's in Q2 2016 and held it in 3 quarters.
  • Stanley-Laman Group's Carter's position peaked at $2.47M in Q4 2016.
  • 337 funds tracked by Wall St. Rank held Carter's as of Q1 2017.

Based on Stanley-Laman Group's 13F filing for Q1 2017, filed 12 May 2017.